EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Remnant Cholesterol with Platelet Reactivity in Coronary Artery Disease Patients Receiving PCI

Menglu Liu iD, Jiawen Li, Kailun Yan, Kexin Zhang, Pei Zhu, Xiaofang Tang, Deshan Yuan, Yuejin Yang, Runlin Gao, Jinqing Yuan, Xueyan Zhao iD

Global Heart · 2025

DOI: 10.5334/gh.1475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Heart, 2025. Verfasst von Menglu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for C…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Artery Disease, Cholesterol, Blood Platelets. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Remnant cholesterol (RC) has received increasing attention and shown to be associated with bleeding and ischemic events in clinical research; however, the mechanisms remain incompletely understood.

Aim

To investigate the relationship between RC and platelet reactivity in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) who received dual antiplatelet therapy with aspirin and clopidogrel.

Methods

A total of 10,724 consecutive PCI patients in China from January 2013 to December 2013 were enrolled. 6,633 patients had the results of thromborlastogram for analysis. Low on-treatment platelet reactivity (LTPR) and high on-treatment platelet reactivity (HTPR) were defined as adenosine diphosphate-induced platelet maximum amplitude of thromborlastogram 47 mm, respectively.

Results

A total of 6,633 PCI patients (mean age, 58.20 ± 10.2 years; male, 77.5%) were finally enrolled. When RC was used as a continuous variable, the multivariate logistic regression showed that RC concentration was negatively associated with LTPR (OR: 0.761, 95% CI 0.609–0.950) and positively associated with HTPR (OR: 1.461, 95% CI 1.151–1.855). For RC quartiles, compared to the lowest quartile (Q1), quartiles 3 and 4 were negatively associated with LTPR (ORQ3: 0.853, 95% CI 0.735–0.990; ORQ4: 0.840, 95% CI 0.707–0.999). Meanwhile, higher quartiles of RC (Q2, Q3, Q4) were positively associated with HTPR (ORQ2: 1.193, 95% CI 1.015–1.402; ORQ3: 1.356, 95% CI 1.152–1.596; ORQ4: 1.404, 95% CI 1.164–1.694).

Conclusions

We reported that RC was associated with clopidogrel-related platelet reactivity in patients undergoing PCI received dual antiplatelet therapy. These results suggest an interaction between lipid and thrombosis, and remind us pay attention to RC levels in PCI patients. Key findings: In the large-scale (n = 6,633) and real-world study, we revealed that RC may modify the platelet reactivity to influence the risk of bleeding and ischemia in PCI patients. Our study firstly reported the relationship between RC and clopidogrel-related platelet reactivity in patients undergoing PCI received dual antiplatelet therapy. The findings may verify the complex interaction between lipid and thrombosis and suggest that RC may be a potential marker associated with platelet reactivity, which warrants further investigation in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCoronary Artery DiseaseCholesterolBlood PlateletsPlatelet ActivationHumansMaleFemaleMiddle AgedPlatelet Aggregation InhibitorsClopidogrelChinaAgedAspirinRetrospective StudiesBiomarkers

Stichwörter der Autor:innen

Cholesterolbleedingischemiapercutaneous coronary interventionplatelet function tests

Substanzen

Platelet Aggregation InhibitorsCholesterolClopidogrelAspirinBiomarkers

Autor:innen und Institutionen

  • National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking…

ORCID-Profile: Menglu Liu, Xueyan Zhao

Zitieren

APA

Liu, M., Li, J., Yan, K., Zhang, K., Zhu, P., Tang, X., Yuan, D., Yang, Y., Gao, R., Yuan, J., & Zhao, X. (2025). Association of Remnant Cholesterol with Platelet Reactivity in Coronary Artery Disease Patients Receiving PCI. Global Heart. https://doi.org/10.5334/gh.1475

Vancouver

Liu M, Li J, Yan K, Zhang K, Zhu P, Tang X, et al. Association of Remnant Cholesterol with Platelet Reactivity in Coronary Artery Disease Patients Receiving PCI. Global Heart. 2025. doi:10.5334/gh.1475

BibTeX
@article{Liu2025,
  author = {Liu, Menglu and Li, Jiawen and Yan, Kailun and Zhang, Kexin and Zhu, Pei and Tang, Xiaofang and Yuan, Deshan and Yang, Yuejin and Gao, Runlin and Yuan, Jinqing and Zhao, Xueyan},
  title = {Association of Remnant Cholesterol with Platelet Reactivity in Coronary Artery Disease Patients Receiving PCI},
  journal = {Global Heart},
  year = {2025},
  doi = {10.5334/gh.1475}
}
Kostenlos starten →